Evidence map›Paper›PMID 28102229›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2017

The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation.

Roberto Frau, Valentina Bini, Alessio Soggiu, Simona Scheggi, Alessandra Pardu, Silvia Fanni, Paola Roncada, Monica Puligheddu, Francesco Marrosu, Donatella Caruso and 2 more

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Pregnenolone Reduces L-Dopa-Induced Dyskinesias in Female Parkinsonian Monkeys.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The adverse effects of pramipexole on probability discounting are not reversed by acute DEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2020
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Roberto FrauDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, Monserrato, Italy.
Valentina BiniDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, Monserrato, Italy.
Alessio Soggiu'L. Spallanzani' Institute, Proteomics Section-Department of Veterinary Sciences and Public Health, University of Milan, Milan, Italy.
Simona ScheggiDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Alessandra ParduDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, Monserrato, Italy.
Silvia FanniDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, Monserrato, Italy.
Paola Roncada'L. Spallanzani' Institute, Proteomics Section-Department of Veterinary Sciences and Public Health, University of Milan, Milan, Italy.
Monica PulighedduTourette Syndrome Center, Monserrato, Italy.
Francesco MarrosuTourette Syndrome Center, Monserrato, Italy.
Donatella CarusoDepartment of Pharmacological and Biomolecular Sciences, Center of Excellence for Neurodegenerative Diseases, University of Milan, Milan, Italy.
Paola DevotoDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, Monserrato, Italy.
Marco BortolatoDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.

Funding

Deciphering gene-environment interactions in pathological reactive aggressionR01MH104603 · NIMH · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Marco Bortolato, Regina A. Mangieri · 2014 to 2026
$6.0M
NIMH NIH HHS R01 MH104603
6 · The paper itself

Abstract

Acute sleep deprivation (SD) can trigger or exacerbate psychosis- and mania-related symptoms; the neurobiological basis of these complications, however, remains elusive. Given the extensive involvement of neuroactive steroids in psychopathology, we hypothesized that the behavioral complications of SD may be contributed by 5α-reductase (5αR), the rate-limiting enzyme in the conversion of progesterone into the neurosteroid allopregnanolone. We first tested whether rats exposed to SD may exhibit brain-regional alterations in 5αR isoenzymes and neuroactive steroid levels; then, we assessed whether the behavioral and neuroendocrine alterations induced by SD may be differentially modulated by the administration of the 5αR inhibitor finasteride, as well as progesterone and allopregnanolone. SD selectively enhanced 5αR expression and activity, as well as AP levels, in the prefrontal cortex; furthermore, finasteride (10-100 mg/kg, IP) dose-dependently ameliorated PPI deficits, hyperactivity, and risk-taking behaviors, in a fashion akin to the antipsychotic haloperidol and the mood stabilizer lithium carbonate. Finally, PPI deficits were exacerbated by allopregnanolone (10 mg/kg, IP) and attenuated by progesterone (30 mg/kg, IP) in SD-subjected, but not control rats. Collectively, these results provide the first-ever evidence that 5αR mediates a number of psychosis- and mania-like complications of SD through imbalances in cortical levels of neuroactive steroids.

Indexed as

5-alpha Reductase InhibitorsAcoustic StimulationAnimalsAntipsychotic AgentsBrainCholestenone 5 alpha-ReductaseDisease Models, AnimalDose-Response Relationship, DrugFinasterideGene Expression Regulation, EnzymologicMalePregnanolonePsychotic DisordersRatsRats, Sprague-DawleyReflex, Startle5-alpha Reductase InhibitorsAntipsychotic AgentsCholestenone 5 alpha-ReductaseFinasteridePregnanoloneSteroids

Identifiers

PMID28102229
PMCPMC5603808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.